Type / Class
Equity / Common Stock, $0.01 par value
Shares outstanding
51.9M
Number of holders
55
Total 13F shares, excl. options
14.4M
Shares change
+293K
Total reported value, excl. options
$105M
Value change
+$6.82M
Put/Call ratio
0.08
Number of buys
36
Number of sells
-18
Price
$7.25

Significant Holders of ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value (ABEO) as of Q1 2024

72 filings reported holding ABEO - ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value as of Q1 2024.
ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value (ABEO) has 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 14.4M shares of 51.9M outstanding shares and own 27.84% of the company stock.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP, L.L.C. (3.25M shares), Nantahala Capital Management, LLC (2.31M shares), MILLENNIUM MANAGEMENT LLC (1.99M shares), Western Standard LLC (1.36M shares), VANGUARD GROUP INC (1.1M shares), Ikarian Capital, LLC (889K shares), Laurion Capital Management LP (647K shares), CITIGROUP INC (484K shares), BOOTHBAY FUND MANAGEMENT, LLC (270K shares), and Walleye Capital LLC (266K shares).
This table shows the top 55 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.